# Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Canonical URL: https://biopharmsignal.com/news/PLSE/pulse-biosciences-announces-strategic-alignment-to-accelerate-cardiac-catheter-program-following-exceptional-long-term-afib-clinical-data
Ticker: PLSE
Company: Pulse Biosciences
Source: Pulse Biosciences
Published: 2026-03-17 11:00 EST
Original Source URL: https://investors.pulsebiosciences.com
## Summary

HAYWARD, Calif. --(BUSINESS WIRE)--Mar. 17, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and accelerate the development and future

## Article Body
HAYWARD, Calif. --(BUSINESS WIRE)--Mar. 17, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and accelerate the development and future
## Recent Company News
- 2026-05-27 20:05 EST — [Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026](https://biopharmsignal.com/news/PLSE/pulse-biosciences-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026) — Source: Pulse Biosciences
- 2026-05-12 11:00 EST — [ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million](https://biopharmsignal.com/news/PLSE/atm-equity-purchases-by-pulse-biosciences-co-chairmen-total-approximately-13-3-million) — Source: Pulse Biosciences
- 2026-05-08 11:00 EST — [Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference](https://biopharmsignal.com/news/PLSE/pulse-biosciences-to-present-at-the-bofa-securities-2026-healthcare-conference) — Source: Pulse Biosciences
- 2026-05-04 11:00 EST — [Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PLSE/pulse-biosciences-reports-business-updates-and-first-quarter-2026-financial-results) — Source: Pulse Biosciences
- 2026-04-25 17:00 EST — [Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026](https://biopharmsignal.com/news/PLSE/pulse-biosciences-presents-positive-outcomes-in-late-breaking-updated-data-from-npulsetm-cardiac-catheter-system-at-heart-rhythm-2026) — Source: Pulse Biosciences
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)